MAFD5
MCID: MJR006
MIFTS: 34

Major Affective Disorder 5 (MAFD5)

Categories: Genetic diseases, Mental diseases

Aliases & Classifications for Major Affective Disorder 5

MalaCards integrated aliases for Major Affective Disorder 5:

Name: Major Affective Disorder 5 57 13 72
Bipolar Affective Disorder; Bpad 57
Bipolar Affective Disorder 57
Bipolar Disorder 72
Mafd5 57
Bpad 57

Classifications:



External Ids:

OMIM 57 611535
MedGen 42 C1970944
UMLS 72 C0005586 C1970944

Summaries for Major Affective Disorder 5

MalaCards based summary : Major Affective Disorder 5, also known as bipolar affective disorder; bpad, is related to bipolar disorder and major affective disorder 1. An important gene associated with Major Affective Disorder 5 is MAFD5 (Major Affective Disorder 5). The drugs Paroxetine and Reboxetine have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and eye.

More information from OMIM: 611535

Related Diseases for Major Affective Disorder 5

Diseases in the Major Affective Disorder 1 family:

Major Affective Disorder 2 Major Affective Disorder 3
Major Affective Disorder 4 Major Affective Disorder 5
Major Affective Disorder 6 Major Affective Disorder 8
Major Affective Disorder 7 Major Affective Disorder 9

Diseases related to Major Affective Disorder 5 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 187)
# Related Disease Score Top Affiliating Genes
1 bipolar disorder 12.3
2 major affective disorder 1 12.1
3 major affective disorder 6 12.1
4 major affective disorder 8 11.9
5 major affective disorder 9 11.9
6 major affective disorder 2 11.8
7 major affective disorder 4 11.8
8 major affective disorder 3 11.6
9 major affective disorder 7 11.6
10 mood disorder 10.7
11 endogenous depression 10.5
12 schizophrenia 10.5
13 depression 10.5
14 mental depression 10.5
15 bipolar i disorder 10.4
16 major depressive disorder 10.4
17 personality disorder 10.3
18 psychotic disorder 10.3
19 schizoaffective disorder 10.3
20 alcohol dependence 10.3
21 tardive dyskinesia 10.3
22 obsessive-compulsive disorder 10.3
23 hypothyroidism 10.2
24 substance abuse 10.2
25 cyclothymic disorder 10.2
26 huntington disease 10.1
27 attention deficit-hyperactivity disorder 10.1
28 mental health wellness 1 10.1
29 mental health wellness 2 10.1
30 severe combined immunodeficiency 10.1
31 multiple sclerosis 10.1
32 autism 10.1
33 thalassemia 10.1
34 hydrocephalus 10.1
35 borderline personality disorder 10.1
36 avoidant personality disorder 10.1
37 adenoma 10.1
38 congenital hydrocephalus 10.1
39 head injury 10.1
40 schizophrenia 1 10.0
41 frontotemporal dementia 10.0
42 anxiety 10.0
43 alacrima, achalasia, and mental retardation syndrome 10.0
44 exanthem 10.0
45 physical disorder 10.0
46 dementia 10.0
47 alcohol use disorder 10.0
48 movement disease 10.0
49 panic disorder 10.0
50 hyperthyroidism 10.0

Graphical network of the top 20 diseases related to Major Affective Disorder 5:



Diseases related to Major Affective Disorder 5

Symptoms & Phenotypes for Major Affective Disorder 5

Clinical features from OMIM:

611535

Drugs & Therapeutics for Major Affective Disorder 5

Drugs for Major Affective Disorder 5 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 457)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
2
Reboxetine Approved, Experimental Phase 4 98769-81-4, 71620-89-8 123628 65856
3
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
4
Galantamine Approved Phase 4 357-70-0 9651
5
Ropinirole Approved, Investigational Phase 4 91374-21-9, 91374-20-8 5095 497540
6
Memantine Approved, Investigational Phase 4 19982-08-2 4054
7
Topiramate Approved Phase 4 97240-79-4 5284627
8
Tranylcypromine Approved, Investigational Phase 4 155-09-9 441233
9
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
10
Cocaine Approved, Illicit Phase 4 50-36-2 446220 5760
11
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
12
Levetiracetam Approved, Investigational Phase 4 102767-28-2 441341
13
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
14
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
15
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
16
Norepinephrine Approved Phase 4 51-41-2 439260
17
Sertraline Approved Phase 4 79617-96-2 68617
18
Nortriptyline Approved Phase 4 72-69-5 4543
19
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
20
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
21
Mirtazapine Approved Phase 4 61337-67-5, 85650-52-8 4205
22
Histamine Approved, Investigational Phase 4 51-45-6 774
23
Ondansetron Approved Phase 4 99614-02-5 4595
24
Iloperidone Approved Phase 4 133454-47-4 71360
25
Brexpiprazole Approved, Investigational Phase 4 913611-97-9 11978813
26
Methohexital Approved Phase 4 151-83-7 9034
27
Dipyridamole Approved Phase 4 58-32-2 3108
28
Chlorpromazine Approved, Investigational, Vet_approved Phase 4 50-53-3 2726
29
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
30
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
31
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
32
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
33
Metformin Approved Phase 4 657-24-9 4091 14219
34
Racepinephrine Approved Phase 4 329-65-7 838
35
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
36
Simvastatin Approved Phase 4 79902-63-9 54454
37
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
38
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 15589840
39
Amphetamine Approved, Illicit, Investigational Phase 4 300-62-9 5826 3007
40
Dextroamphetamine Approved, Illicit Phase 4 51-64-9 5826
41
Acetaminophen Approved Phase 4 103-90-2 1983
42
Angiotensin II Approved, Investigational Phase 4 11128-99-7, 68521-88-0, 4474-91-3 172198
43
Losartan Approved Phase 4 114798-26-4 3961
44
Loxapine Approved Phase 4 1977-10-2 3964
45
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
46
Eleuthero Approved, Experimental Phase 4
47
Oxcarbazepine Approved Phase 4 28721-07-5 34312
48
Clozapine Approved Phase 4 5786-21-0 2818
49
Nicotine Approved Phase 4 54-11-5 942 89594
50
Promethazine Approved, Investigational Phase 4 60-87-7 4927

Interventional clinical trials:

(show top 50) (show all 1439)
# Name Status NCT ID Phase Drugs
1 An Open Label, Multicenter, Single Arm, 4-Week Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder Unknown status NCT00837343 Phase 4 quetiapine fumarate tablet (Seroquel)
2 Effects of N-Acetyl-Cysteine on Oxidative Stress Biomarkers in Bipolar Patients With and Without Tobacco Use Disorder Unknown status NCT02252341 Phase 4
3 Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder Unknown status NCT00608075 Phase 4 lithium;Lithium
4 Exploring Alterations of Central Autonomic Modulation in Patients With Bipolar Depression Unknown status NCT01213121 Phase 4 Quetiapine
5 A Randomized, Double-blind, Placebo-controlled Study of Quetiapine SR and Divalproex Sodium ER on Anxiety in Bipolar Disorder With at Least Moderately Severe Current Anxiety and Lifetime Panic or Generalized Anxiety Disorder. Unknown status NCT00579280 Phase 4 quetiapine SR;divalproex sodium ER;placebo
6 Assessing the Efficacy of Left Repetitive Transcranial Magnetic Stimulation (rTMS) as an Adjunctive Treatment to Mood Stabilizers for the Treatment of Bipolar Depression Unknown status NCT01583023 Phase 4 Bupropion
7 Assessment and Follow Up Study of Children and Adolescent With Bipolar Disorder Unknown status NCT01000402 Phase 4 Psychopharmacotherapy
8 A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression. Unknown status NCT00335205 Phase 4 ropinirole
9 Clinical Psychopharmacology Division Institute of Mental Health, Peking University Unknown status NCT03148535 Phase 4 Lithium Carbonate;lithium carbonate combined with SSRI antidepressant treatment
10 A Randomized Open-label Active-controlled Study to Evaluate the Efficacy and Safety of Utapine Versus Seroquel in Patients With Bipolar Mania Unknown status NCT01043679 Phase 4 Utapine;Seroquel
11 Comparative Efficacy and Acceptability of Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, and Ziprasidone in Bipolar I Disorder, Manic or Mixed Phase Unknown status NCT01893229 Phase 4 Lithium;Valproate;Oxcarbazepine;Quetiapine;Olanzapine;Ziprasidone
12 Open Label Prophylaxis Study of Lithium Plus Extended- Release Carbamazepine (Equetro®) Combination for Rapid Cycling Bipolar Disorder Unknown status NCT00325286 Phase 4 Lithium Plus Extended- Release Carbamazepine
13 Reduction of Cardiovascular Risk in Severe Mental Illness Prescribing and Using Better and More Appropriated Drugs Unknown status NCT01182012 Phase 4
14 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in PCOS Patients. Unknown status NCT01246310 Phase 4
15 Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia by Aripiprazole Add-on Therapy in the Treatment of Schizophrenia and Bipolar Disorder: An Open-Label Trial Unknown status NCT00541554 Phase 4 Abilify (aripiprazole)
16 Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study Unknown status NCT00426946 Phase 4 Reboxetine
17 The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope Unknown status NCT01357967 Phase 4 SSRI monotherapy;Seroquel XR adjunctive
18 A Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression Completed NCT00186758 Phase 4
19 Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy: A Randomized Controlled Trial Completed NCT03863925 Phase 4
20 Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness. Completed NCT00067938 Phase 4 lamotrigine
21 An Open-Label Extension Study to Assess the Safety of Lamotrigine in Subjects With Bipolar Disorder, Who Are in Remission Following a Manic/Hypomanic Index Episode or a Depressive Index Episode. Completed NCT00360126 Phase 4 lamotrigine
22 Lamictal As Add on Treatment in Mixed States of Bipolar Disorder Completed NCT00223509 Phase 4 Lamotrigine
23 Multi-center, Double-blind, Randomized, Comparative Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify and Depakote in 24-week Treatment of Mania in Patients With Bipolar Disorder Remitted After 6-week Treatment With Abilify and Depakote Completed NCT00545675 Phase 4 Abilify(aripiprazole);Depakote (divalproate)
24 Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder Completed NCT00545142 Phase 4 Abilify(Aripiprazole);Depakote(Divalproate)
25 Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder Completed NCT00050206 Phase 4 Olanzapine;Placebo
26 A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder Completed NCT00139594 Phase 4 licarbazepine
27 Adjunctive Ziprasidone in Overweight and Obese Patients With Bipolar Disorder Completed NCT00472641 Phase 4 Ziprasidone/Geodon
28 Quetiapine for Bipolar Disorder and Alcohol Dependence Completed NCT00457197 Phase 4 Placebo;Quetiapine
29 A Randomized, Double-Blind, Placebo Controlled Study Of Quetiapine SR (QTP) As Adjunctive Treatment In Mixed States (MS) Of Bipolar Disorder Completed NCT01195363 Phase 4 quetiapine SR;quetiapine sr placebo
30 Aripiprazole in Late Life Bipolar Disorder Completed NCT00194038 Phase 4 Aripiprazole
31 A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder Completed NCT00314821 Phase 4 ropinirole
32 Cognitive Enhancement in Bipolar Disorder Completed NCT00597896 Phase 4 pramipexole
33 Memantine and Cognitive Dysfunction in Bipolar Disorder Completed NCT00586066 Phase 4 Memantine;Placebo
34 Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression Completed NCT00485771 Phase 4 Olanzapine;Fluoxetine;Lamotrigine
35 Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study Completed NCT00477373 Phase 4 depakine chrono
36 Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder Completed NCT00190892 Phase 4 olanzapine;carbamazepine
37 Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed Completed NCT00034580 Phase 4 olanzapine;risperidone
38 Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder Completed NCT00572117 Phase 4 Topiramate
39 Tranylcypromine Treatment of Bipolar Depression Completed NCT01430455 Phase 4 Tranylcypromine
40 Depakote ER Therapy for Mania Comorbid With Substance Abuse Completed NCT00208195 Phase 4 Divalproex ER
41 A Phase IV STudy of the Effectiveness of Quetiapine Extended Release 600mg Once a Day to Control the Symptoms of Manic Phase of Bipolar Disorder. Completed NCT00521365 Phase 4 Quetiapine 600mg
42 A Double-Blind, Randomized, Placebo-Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder. Completed NCT00552760 Phase 4 Ramelteon;Placebo
43 A Double Blind, Randomized, Placebo Controlled Trial of Aripiprazole Plus Valproate in the Short-Term and Long-Term Treatment of Bipolar Disorder Completed NCT00484471 Phase 4 aripiprazole;valproate;placebo
44 A Phase 4 Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder Completed NCT00195845 Phase 4 Galantamine;Placebos
45 Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated With Bipolar I Disorder Completed NCT00094549 Phase 4 olanzapine;divalproex sodium;placebo
46 A Double-Blind, Placebo-Controlled Trial of Lamotrigine In Individuals With Bipolar Disorder and Comorbid Alcohol Dependence Completed NCT01015586 Phase 4 Lamotrigine;Placebo
47 Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder Completed NCT01331304 Phase 4 Lithium;Quetiapine
48 Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression Completed NCT00226343 Phase 4 Depakote-ER
49 Bipolar Depression Assessment Study on Tx Response Completed NCT00191399 Phase 4 Olanzapine;Fluoxetine
50 A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression Completed NCT00363337 Phase 4 aripiprazole

Search NIH Clinical Center for Major Affective Disorder 5

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Carbamazepine
Clonazepam
Clozapine
CLOZAPINE (CARACO)
CLOZAPINE (CLOZARIL)
CLOZAPINE (IVAX)
CLOZAPINE (TEVA)
CLOZAPINE (VERSACLOZ)
Divalproex Sodium
Fazaclo
gabapentin
gabapentin enacarbil
lamotrigine
Lithium
Lithium Aspartate
Lithium Carbonate
lithium citrate
Mylan brand of clozapine
olanzapine
quetiapine
Quetiapine fumarate
Risperidone
Sodium Valproate
tiagabine
Tiagabine hydrochloride
topiramate
UDL brand of clozapine
Valproic Acid

Genetic Tests for Major Affective Disorder 5

Anatomical Context for Major Affective Disorder 5

MalaCards organs/tissues related to Major Affective Disorder 5:

41
Brain, Testes, Eye, Heart, Cortex, Prefrontal Cortex, Bone

Publications for Major Affective Disorder 5

Articles related to Major Affective Disorder 5:

(show top 50) (show all 195)
# Title Authors PMID Year
1
The first genomewide interaction and locus-heterogeneity linkage scan in bipolar affective disorder: strong evidence of epistatic effects between loci on chromosomes 2q and 6q. 38 8
17924339 2007
2
Attitude and perceptions of patients towards long acting depot injections (LAIs). 38
31419737 2019
3
Add-on HD-tDCS for obsessive-compulsive disorder with comorbid bipolar affective disorder: A case series. 38
31108398 2019
4
Risk tolerance measured by probability discounting among individuals with primary mood and psychotic disorders. 38
30688494 2019
5
Blood-Letting Therapy for Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 38
29959751 2019
6
59 "Lithium Damaged My Spine" Might not Be a Delusion After All. 38
30859981 2019
7
Periodontal condition and levels of bacteria associated with periodontitis in individuals with bipolar affective disorders: A case-control study. 38
30207388 2019
8
Predominant Polarity in Bipolar Affective Disorder: A Scoping Review of Its Relationship with Clinical Variables and Its Implications. 38
30783303 2019
9
Clinical Practice Guidelines for Bipolar Affective Disorder (BPAD) in Children and Adolescents. 38
30745704 2019
10
Video-assisted teaching versus traditional didactic lecture in undergraduate psychiatry teaching. 38
31391641 2019
11
Sudden death in patients with serious mental illness. 38
30543613 2018
12
Concise Chemistry Modulation of the SMM Behavior within a Family of Mononuclear Dy(III) Complexes. 38
30422647 2018
13
In the Realm of Psychoneuroimmunology: The Role of Celecoxib as an Add-On Treatment for Bipolar Mania. 38
30643790 2018
14
A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder. 38
30185780 2018
15
Is Internet Addiction a Clinical Symptom or a Psychiatric Disorder? A Comparison With Bipolar Disorder. 38
30028359 2018
16
Polycystic Ovary Syndrome in Bipolar Affective Disorder: A Hospital-based Study. 38
29962567 2018
17
Bipolar Affective Disorder in a Patient of Profound Deafness. 38
29482712 2018
18
Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study. 38
29415689 2018
19
Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. 38
29121268 2018
20
Effectiveness of Mindfulness-based Cognitive Therapy in Patients with Bipolar Affective Disorder: A Case Series. 38
29343935 2018
21
Positive Aspects of Caregiving and Its Correlates among Caregivers of Bipolar Affective Disorder. 38
29259143 2017
22
Internalized stigma and its impact in Indian outpatients with bipolar disorder. 38
29028582 2017
23
Pilot study of a culturally adapted psychoeducation (CaPE) intervention for bipolar disorder in Pakistan. 38
28155203 2017
24
A Rare Presentation of a Case of Obsessive-compulsive Disorder Comorbid with Bipolar Affective Disorder. 38
29284814 2017
25
Prevalence and Sociodemographic Profile of Lithium-induced Cutaneous Side Effects in Bipolar Affective Disorder Patients: A 1-year Prospective Observational Study in South India. 38
29200562 2017
26
The effect of chinese herbal medicine Banxia Baizhu Tianma Decoction for the treatment of vertebrobasilar insufficiency vertigo: A systematic review and meta-analysis of randomized controlled trials. 38
28434468 2017
27
Tuning of Exchange Coupling and Switchable Magnetization Dynamics by Displacing the Bridging Ligands Observed in Two Dimeric Manganese(III) Compounds. 38
28322305 2017
28
Metal Ion Complexes of N,N'-Bis(2-Pyridylmethyl)-trans-1,2-Diaminocyclohexane-N,N'-Diacetic Acid, H2bpcd: Lanthanide(III)-bpcd2- Cationic Complexes. 38
28267320 2017
29
Impact of Pharmacist-Psychiatrist Collaborative Patient Education on Medication Adherence and Quality of Life (QOL) of Bipolar Affective Disorder (BPAD) Patients. 38
29066976 2017
30
Outcomes of Renal Transplantation in Patients With Bipolar Affective Disorder and Schizophrenia: A National Retrospective Cohort Study. 38
27887740 2017
31
Integrated exposure and risk characterization of bisphenol-A in Europe. 38
27769850 2016
32
Distressing cutaneous lesion among bipolar affective disorder patients on lithium therapy: A retrospective cross-sectional study. 38
28196994 2016
33
Polycystic ovary syndrome in patients on antiepileptic drugs. 38
27570385 2016
34
Lifestyle related factors & impact of metabolic syndrome on quality of life, level of functioning & self-esteem in patients with bipolar disorder & schizophrenia. 38
27377499 2016
35
Metal Ion Complexes of N,N'-Bis(2-Pyridylmethyl)-trans-1,2-Diaminocyclohexane-N,N'-Diacetic Acid, H2bpcd: Cis/Trans Isomerization Equilibria. 38
26478942 2015
36
Safe tracheostomy: blunt puncture and dilation after minimal surgical exposure of the trachea (BPAD tracheostomy). 38
26509003 2015
37
Disruption of sonic hedgehog signaling in Ellis-van Creveld dwarfism confers protection against bipolar affective disorder. 38
25311364 2015
38
SEQUenCE: a service user-centred quality of care instrument for mental health services. 38
26082461 2015
39
Estimation of in vivo dose of dermally applied chemicals leading to estrogen/androgen receptor-mediated toxicity from in vitro data--Illustration with four reproductive toxicants. 38
25597788 2015
40
Seasonal Affective Disorder (SAD): Role of Lamotrigine Augmentation to Anti-Depressant Medication in Winter Depression. 38
26664074 2015
41
A systematic review and meta-analysis of premature mortality in bipolar affective disorder. 38
25735195 2015
42
Available screening tools for adults suffering from bipolar affective disorder in primary care: An integrative literature review. 38
25691013 2015
43
A comparative study of caregivers' perceptions of health-care needs and burden of patients with bipolar affective disorder and schizophrenia. 38
25928091 2015
44
Overlap between autism spectrum disorder and bipolar affective disorder. 38
26278909 2015
45
Effect of Sudarshan Kriya on male prisoners with non psychotic psychiatric disorders: a randomized control trial. 38
25440560 2014
46
A common microdeletion affecting a hippocampus- and amygdala-specific isoform of tryptophan hydroxylase 2 is not associated with affective disorders. 38
24754353 2014
47
Neuro-cognitive functioning in unaffected siblings of patients with bipolar disorder: Comparison with bipolar patients and healthy controls. 38
25316940 2014
48
Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder. 38
25097292 2014
49
Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome. 38
24817687 2014
50
Comparison between an automated device and a manual mercury sphygmomanometer in an epidemiological survey of hypertension prevalence. 38
23764377 2014

Variations for Major Affective Disorder 5

Expression for Major Affective Disorder 5

Search GEO for disease gene expression data for Major Affective Disorder 5.

Pathways for Major Affective Disorder 5

GO Terms for Major Affective Disorder 5

Sources for Major Affective Disorder 5

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....